Abstract
Background
Patients with celiac disease (CeD) can commonly present with symptoms of dyspepsia. We conducted a systematic review and meta-analysis of the present literature to assess the prevalence of CeD in patients diagnosed with dyspepsia.
Methods
We searched MEDLINE and EMBASE databases for the keywords: celiac disease, coeliac disease, anti-gliadin, tissue transglutaminase antibody, anti-endomysial antibody, dyspepsia and functional gastrointestinal disorder. All the studies published from January 1991 till May 2021 were included. Diagnosis of CeD was based on the European Society of Pediatric Gastroenterology, Hepatology and Nutrition guidelines. A random-effects model was used to pool the data.
Results
Twenty-one studies screening 10,275 patients with dyspepsia were included. The pooled seroprevalence of CeD based on a positive anti-tissue transglutaminase antibody and/or anti-endomysial antibody was 4.8% (95% CI [2.8, 6.7%], I2 = 87.7%). The pooled biopsy-confirmed CeD prevalence was 1.5% (95% CI [1.0, 1.9%]; I2 = 59.8%) in these patients. Both seroprevalence (Odds ratio: 1.8; 95% CI [0.8, 4.0%]; I2 = 0%) and prevalence of biopsy-confirmed CeD (Odds ratio: 1.4; 95% CI [0.8, 2.4]; I2 = 0%) were not higher in patients with dyspepsia compared to controls. There was a moderate risk of selection bias and significant heterogeneity in the pooled results.
Conclusions
The pooled prevalence of CeD in patients with dyspepsia was 1.5% and it was not significantly higher than the general population. These results do not support screening of patients with dyspepsia for CeD.
Similar content being viewed by others
References
Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2018;16:823-836.e2.
Jericho H, Guandalini S. Extra-intestinal manifestation of celiac disease in children. Nutrients. 2018;10:755.
Singh AD, Singh P, Farooqui N, Strand T, Ahuja V, Makharia GK. Prevalence of celiac disease in patients with short stature: A systematic review and Meta-analysis. J Gastroenterol Hepatol. 2020 Jul 3;
US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, et al. Screening for celiac disease: US preventive services task force recommendation statement. JAMA. 2017;317(12):1252–7.
Talley NJ, Walker MM. Celiac Disease and Nonceliac Gluten or Wheat Sensitivity: The Risks and Benefits of Diagnosis. JAMA Intern Med. 2017;177:615–616.
Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64:1049–1057.
Mahadeva S, Goh K-L. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol. 2006;12:2661–2666.
Talley NJ, Ford AC. Functional dyspepsia. N Engl J Med. 2015;373:1853–1863.
Moayyedi P, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017;112:988–1013.
Ford AC, Ching E, Moayyedi P. Meta-analysis: yield of diagnostic tests for coeliac disease in dyspepsia. Aliment Pharmacol Ther. 2009;30:28–36.
Cristofori F, Bentivoglio V, Raguseo LC, Tripaldi ME, Gentile A, Giordano P et al. Increased prevalence of abdominal pain-functional gastrointestinal disorders in pediatric celiac patients despite a strict gluten free diet. J Pediatr Gastroenterol Nutr. 2018;66:415.
Kansu A, Kulotlu Z, Demir A, Yaman A. Yield of coeliac screening in abdominal pain-associated functional gastrointestinal system disorders. J Paediatr Child Health. 2015;51:1066–1070.
Keshavarz AA, Bashiri H, Ahmadi A, Bazargan-Hejazi S. The prevalence of occult celiac disease among patients with functional dyspepsia: a study from the western region of Iran. Gastroenterol Res Pract. 2010;2010:170702.
Lasa J, Spallone L, Gandara S, Chaar E, Berman S, Zagalsky D. Celiac disease prevalence is not increased in patients with functional dyspepsia. Arq Gastroenterol. 2017;54:37–40.
Majeed AAA, Shaalan HK, Hussein BA, Homadi S. Prevalence of Celiac Disease in Dyspeptic Patients. Karbala J. Med. 2017;10(3):3833–3840.
Rostami Nejad M, Dabiri R, Ehsani-Ardakani MJ, Nazemalhosseini Mojarad E, Derakhshan F, Telkabadi M et al. Gluten associated dyspepsia; serology and histological characteristics. Gastroenterol Hepatol Bed Bench. 2012;5:197–201.
Sharma H, Verma AK, Das P, Dattagupta S, Ahuja V, Makharia GK. Prevalence of celiac disease in Indian patients with irritable bowel syndrome and uninvestigated dyspepsia. J Dig Dis. 2015;16:443–448.
Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–160.
Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. [Internet]. [cited 2019 Jan 18]. Available from: http://handbook.cochrane.org
Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65:934–939.
Deeks JJ, Higgins JPT, Altman DG. 9.5.2 Identifying and measuring heterogeneity [Internet]. [cited 2019 Sep 3]. Available from: https://handbook-5-1.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm
Altintas E, Senli MS, Sezgin O. Prevalence of celiac disease among dyspeptic patients: A community-based case-control study. Turk J Gastroenterol. 2008;19:81–84.
Bardella MT, Minoli G, Ravizza D, Radaelli F, Velio P, Quatrini M et al. Increased prevalence of celiac disease in patients with dyspepsia. Arch Intern Med. 2000;160:1489–1491.
Cammarota G, Pirozzi GA, Martino A, Zuccala G, Cianci R, Cuoco L et al. Reliability of the “immersion technique” during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsia. Gastrointest Endosc. 2004;60:223–228.
Collin P, Rasmussen M, Kyronpalo S, Laippala P, Kaukinen K. The hunt for coeliac disease in primary care. QJM Mon J Assoc Physicians. 2002;95:75–77.
Fraquelli M, Colli A, Colucci A, Bardella MT, Trovato C, Pometta R et al. Accuracy of ultrasonography in predicting celiac disease. Arch Intern Med. 2004;164:169–174.
Frazzoni M, Lonardo A, Grisendi A, Della Casa G, Pulvirenti M, Ferrari AM et al. Are routine duodenal and antral biopsies useful in the management of “functional” dyspepsia? A diagnostic and therapeutic study. J Clin Gastroenterol. 1993;17:101–108.
Giangreco E, D’agate C, Barbera C, Puzzo L, Aprile G, Naso P et al. Prevalence of celiac disease in adult patients with refractory functional dyspepsia: value of routine duodenal biopsy. World J Gastroenterol. 2008;14:6948–6953.
da Silva Kotze LM, Rodrigues APB, Kotze LR, Nisihara RM. A Brazilian experience of the self transglutaminase-based test for celiac disease case finding and diet monitoring. World J Gastroenterol. 2009;15:4423–4428.
Lecleire S, Di Fiore F, Antonietti M, Savoye G, Lemoine F, Le Pessot F et al. Endoscopic markers of villous atrophy are not useful for the detection of celiac disease in patients with dyspeptic symptoms. Endoscopy. 2006;38:696–701.
de Lima VM, Gandolfi L, de Pires JA, Pratesi R. Prevalence of celiac disease in dyspeptic patients. Arq Gastroenterol. 2005;42:153–156.
Locke GR 3rd, Murray JA, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc. 2004;79:476–482.
Ozaslan E, Akkorlu S, Eskioglu E, Kayhan B. Prevalence of silent celiac disease in patients with dyspepsia. Dig Dis Sci. 2007;52:692–697. https://doi.org/10.1007/s10620-006-9453-1.
Vivas S, Ruiz de Morales JM, Martinez J, Gonzalez MC, Martin S, Martin J, et al. Human recombinant anti-transglutaminase antibody testing is useful in the diagnosis of silent coeliac disease in a selected group of at-risk patients. Eur J Gastroenterol Hepatol. 2003;15(5):479–83.
Behforouz A, Faravani E, Esmaeelzadeh A, Mozaffari HM, Mokhtarifar A, Goshayeshi L, et al. Routine Multiple Duodenal Biopsy during Endoscopy of Dyspeptic Patients Seems Unnecessary for Screening of Celiac Disease. Gastroenterol Res Pract. 2020;2020((Behforouz, Faravani) Radiology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, Islamic Republic of):6664741.
Nyrén O, Adami H-O, Gustavsson S, Lindgren PG, Lööf L, Nyberg A. The, “Epigastric Distress Syndrome”: A possible disease entity identified by history and endoscopy in patients with nonulcer dyspepsia. J Clin Gastroenterol. 1987;9:303–309.
Agreus L, Svardsudd K, Tibblin G, Lavo B. Endomysium antibodies are superior to gliadin antibodies in screening for coeliac disease in patients presenting supposed functional gastrointestinal symptoms. Scand J Prim Health Care. 2000;18:105–110.
Incarbone S, Aprile G, Puzzo L, Bonanno G, Naso P, D', et al. Bioptic evaluation of duodenal mucosa in adult dyspeptic patients (PTS): High prevalence of celiac disease (CD). A prospective study. Dig Liver Dis [Internet]. [cited 2020 Aug 15];38. Available from: https://www.academia.edu/29391489/Bioptic_evaluation_of_duodenal_mucosa_in_adult_dyspeptic_patients_PTS_High_prevalence_of_celiac_disease_CD_A_prospective_study
Heikkinen M, Pikkarainen P, Takala J, Räsänen H, Julkunen R. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol. 1995;30:519–523.
Hopper AD, Chew TS, Lewis A, Sanders DS. Is there a case for routine duodenal biopsy at gastroscopy or is a targeted approach adequate? Endoscopy. 2008;40:727–730.
Magazzu G, Bottari M, Tuccari G, Arco A, Pallio S, Lucanto C, et al. Upper gastrointestinal endoscopy can be a reliable screening tool for celiac sprue in adults. J Clin Gastroenterol. 1994 Oct;19(3):255–7; discussion 257–258.
Tack J, Talley NJ. Functional dyspepsia–symptoms, definitions and validity of the Rome III criteria. Nat Rev Gastroenterol Hepatol. 2013;10:134–141.
Baber KF, Anderson J, Puzanovova M, Walker LS. Rome II versus Rome III classification of functional gastrointestinal disorders in pediatric chronic abdominal pain. J Pediatr Gastroenterol Nutr. 2008;47:299–302.
Stahl MG, Geno Rasmussen C, Dong F, Waugh K, Norris JM, Baxter J et al. Mass screening for celiac disease: the autoimmunity screening for kids study. Off J Am Coll Gastroenterol ACG. 2021;116:180–187.
Forbes GM. “ASKing” the right questions about screening for celiac disease. Am J Gastroenterol. 2021;116:82–83.
Enck P, Azpiroz F, Boeckxstaens G, Elsenbruch S, Feinle-Bisset C, Holtmann G et al. Functional dyspepsia. Nat Rev Dis Primer. 2017;3:17081.
Singh P, Singh A, Silvester JA, Sachdeva V, Chen X, Xu H, et al. Inter- and intra-assay variation in the diagnostic performance of assays for anti-tissue transglutaminase in 2 populations. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2019;18(11):2628–2630.
Li M, Yu L, Tiberti C, Bonamico M, Taki I, Miao D et al. A report on the international transglutaminase autoantibody workshop for celiac disease. Am J Gastroenterol. 2009;104:154–163.
Lebwohl B, Rubio-Tapia A. Epidemiology, presentation, and diagnosis of celiac disease. Gastroenterology. 2021;160:63–75.
The best research databases for healthcare and medicine [Update 2019] [Internet]. Paperpile. [cited 2020 Dec 25]. Available from: https://paperpile.com/g/research-databases-healthcare/
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix: Search Strategy
Appendix: Search Strategy
Ovid MEDLINE(R) ALL < 1946 to December 11, 2020 >
Embase < 1974 to 2020 December 10 > (Updated May 10, 2021).
-
1.
celiac disease.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 61164
-
2.
coeliac disease.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 16131
-
3.
gluten.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 36693
-
4.
gliadin.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 11878
-
5.
tissue transglutaminase.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 9027
-
6.
endomysium.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 5163
-
7.
anti-endomysial antibody.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 304
-
8.
sprue.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 6187
-
9.
intestinal atrophy.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 402
-
10.
1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 984561
-
11.
limit 10 to yr = "1990 -Current" 70580
-
12.
dyspepsia.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 56119
-
13.
epigastric pain.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 29022
-
14.
satiety.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 33672
-
15.
upper gastrointestinal symptoms.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 2758
-
16.
nausea.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 414540
-
17.
post prandial fullness.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 168
-
18.
refractory dyspepsia.mp. [mp = ti, ab, tx, ct, ot, nm, hw, fx, kf, ox, px, rx, ui, sy, tn, dm, mf, dv, kw, dq] 24
-
19.
12 or 13 or 14 or 15 or 16 or 17 or 18504127
-
20.
limit 19 to yr = "1990 -Current" 469010
-
21.
11 and 203048
-
22.
remove duplicates from 212608
Rights and permissions
About this article
Cite this article
Singh, A.D., Ellias, S., Singh, P. et al. The Prevalence of the Celiac Disease in Patients with Dyspepsia: A Systematic Review and Meta-Analysis. Dig Dis Sci 67, 3067–3079 (2022). https://doi.org/10.1007/s10620-021-07142-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-021-07142-8